Spots Global Cancer Trial Database for front line mobilization
Every month we try and update this database with for front line mobilization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). | NCT00838357 | Lymphoma (Non-H... Hodgkin's Disea... Front Line Mobi... Transplantation | Generic = Pleri... | 18 Years - | Sanofi | |
A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). | NCT00838357 | Lymphoma (Non-H... Hodgkin's Disea... Front Line Mobi... Transplantation | Generic = Pleri... | 18 Years - | Sanofi |